Working… Menu
Trial record 5 of 9 for:    "Thrombocytopenia" | "alemtuzumab"

CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01966367
Recruitment Status : Recruiting
First Posted : October 21, 2013
Last Update Posted : March 14, 2019
Information provided by (Responsible Party):
Diane George, MD, Columbia University

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2019
Estimated Study Completion Date : December 2019